Euna B. Koo

Euna B. Koo

Auto-generated profile, based on publicly available information

Euna B. Koo

Department of Ophthalmology, Byers Eye Institute, Horngren Family Vitreoretinal Center, Stanford University School of Medicine, Palo Alto, CA 94303, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2018 in Genes
Verified
Journal Article
Open access
PDF file
SWStephanie Wang
Stephanie Wang
TKTia Judeen Kowal
Tia Judeen Kowal
KNKe Ning
Ke Ning
EKEuna B. Koo
Euna B. Koo
AWAlbert Y. Wu
Albert Y. Wu
YSYang Sun
Yang Sun
Joubert syndrome is a group of rare disorders that stem from defects in a sensory organelle, the primary cilia. Affected patients often present with disorders involving multiple organ systems, including the brain, eyes, and kidneys. Common symptoms include breathing abnormalities, mental developmental delays, loss of voluntary muscle coordination, and abnormal eye movements, with a diagnostic “molar tooth” sign observed by magnetic resonance imaging (MRI) of the midbrain. We reviewed the ocular phenotypes that can be found in patients with Joubert syndrome. Ocular motor apraxia is the most frequent (80% of patients), followed by strabismus (74%) and nystagmus (72%). A minority of patients also present with ptosis (43%), chorioretinal coloboma (30%), and optic nerve atrophy (22%). Although mutations in 34 genes have been found to be associated with Joubert syndrome, retinal degeneration has been reported in only 38% of patients. Mutations in AHI1 and CEP290, genes critical to primary cilia function, have been linked to retinal degeneration. In conclusion, Joubert syndrome is a rare pleiotropic group of disorders with variable ocular presentations.

17 April 2024 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
KWKaren Wai
Karen Wai
KMKapil Mishra
Kapil Mishra
EKEuna Koo
Euna Koo
CLCassie Ann Ludwig
Cassie Ann Ludwig
RPRavi Parikh
Ravi Parikh
EREhsan Rahimy
Ehsan Rahimy

26 October 2023 in Survey of Ophthalmology
Verified
Journal Article
Open access
AAAsim Ali
Asim Ali
LBLeonard Bielory
Leonard Bielory
SDStephanie Dotchin
Stephanie Dotchin
PHPatrick Hamel
Patrick Hamel
YSYi Ning J. Strube
Yi Ning J. Strube
EKEuna B. Koo
Euna B. Koo
Vernal keratoconjunctivitis (VKC) is a chronic, progressive, and potentially sight-threatening form of ocular inflammatory disease that primarily affects children and young adults. Prevalence varies by region, ranging from <2 per 10,000 in in the United States to as high as 1,100 per 10,000 in parts of Africa. The rarity of VKC in developed countries can make differential diagnosis challenging, and treatment is often delayed until the disease is advanced, and symptoms are significantly impacting patients' quality of life. Although once viewed primarily as an immunoglobulin E-mediated condition, approximately 50% of patients with VKC do not exhibit allergic sensitization. It is now recognized that the immunopathology of VKC involves multiple inflammatory pathways that lead to the signs, symptoms, and conjunctival eosinophilic and fibroproliferative lesions that are a hallmark of the disease. We examine the evolution of our understanding of the immunopathology of VKC, the expanding VKC treatment armamentarium, the clinical implications of emerging treatment approaches, and future directions for VKC research and practice.

1 September 2023 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
KWKaren Wai
Karen Wai
CLCassie A. Ludwig
Cassie A. Ludwig
EKEuna Koo
Euna Koo
RPRavi Parikh
Ravi Parikh
PMPrithvi Mruthyunjaya
Prithvi Mruthyunjaya
EREhsan Rahimy
Ehsan Rahimy

16 May 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CLChien-Hui Lo
Chien-Hui Lo
ZLZhiquan Liu
Zhiquan Liu
SCSiyu Chen
Siyu Chen
FLFrank Lin
Frank Lin
ABAndrew R. Berneshawi
Andrew R. Berneshawi
YSYang Sun
Yang Sun
Mitochondria-related neurodegenerative diseases have been implicated in the disruption of primary cilia function. Mutation in an intrinsic mitochondrial complex I component NDUFAF2 has been identified in Leigh syndrome, a severe inherited mitochondriopathy. Mutations in ARMC9 , which encodes a basal body protein, cause Joubert syndrome, a ciliopathy with defects in the brain, kidney, and eye. Here, we report a mechanistic link between mitochondria metabolism and primary cilia signaling. We discovered that loss of NDUFAF2 caused both mitochondrial and ciliary defects in vitro and in vivo and identified NDUFAF2 as a binding partner for ARMC9. We also found that NDUFAF2 was both necessary and sufficient for cilia formation and that exogenous expression of NDUFAF2 rescued the ciliary and mitochondrial defects observed in cells from patients with known ARMC9 deficiency. NAD + supplementation restored mitochondrial and ciliary dysfunction in ARMC9-deficient cells and zebrafish and ameliorated the ocular motility and motor deficits of a patient with ARMC9 deficiency. The present results provide a compelling mechanistic link, supported by evidence from human studies, between primary cilia and mitochondrial signaling. Importantly, our findings have significant implications for the development of therapeutic approaches targeting ciliopathies.

31 July 2024 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
EREhsan Rahimy
Ehsan Rahimy
EKEuna B. Koo
Euna B. Koo
KWKaren M. Wai
Karen M. Wai
CLCassie A. Ludwig
Cassie A. Ludwig
AKAndrea Lora Kossler
Andrea Lora Kossler
PMPrithvi Mruthyunjaya
Prithvi Mruthyunjaya